Liver transplantation for maple syrup urine disease: A global domino effect
Neslihan Celik
Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
Search for more papers by this authorRobert H. Squires
Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
Search for more papers by this authorJerry Vockley
Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
Search for more papers by this authorRakesh Sindhi
Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
Search for more papers by this authorGeorge Mazariegos
Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
Search for more papers by this authorNeslihan Celik
Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
Search for more papers by this authorRobert H. Squires
Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
Search for more papers by this authorJerry Vockley
Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
Search for more papers by this authorRakesh Sindhi
Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
Search for more papers by this authorGeorge Mazariegos
Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
Search for more papers by this author
References
- 1Neelam Mohan DSK, Rastogi A, Vohra V, Soin AS. Living donor liver transplantation in maple syrup urine disease – case series and world's youngest domino liver donor and recipient. Pediatr Transplant 2016: 20: 395–400.
- 2Strauss KA, Mazariegos GV, Sindhi R, et al. Elective liver transplantation for the treatment of classical maple syrup urine disease. Am J Transplant 2006: 6: 557–564.
- 3Mazariegos GV, Morton DH, Sindhi R, et al. Liver transplantation for classical maple syrup urine disease: Long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience. J Pediatr 2012: 160: 116–121 e1.
- 4Petrowsky H, Brunicardi FC, Leow VM, et al. Liver transplantation for lethal genetic syndromes: A novel model of personalized genomic medicine. J Am Coll Surg 2013: 216: 534–543; discussion 43–4.
- 5Feier FH, Miura IK, Fonseca EA, et al. Successful domino liver transplantation in maple syrup urine disease using a related living donor. Braz J Med Biol Res 2014: 47: 522–526.
- 6Kadohisa M, Matsumoto S, Sawada H, et al. Living donor liver transplantation from a heterozygous parent for classical maple syrup urine disease. Pediatr Transplant 2015: 19: E66–E69.
- 7Patel N, Loveland J, Zuckerman M, Moshesh P, Britz R, Botha J. Heterozygote to homozygote related living donor liver transplantation in maple syrup urine disease: A case report. Pediatr Transplant 2015: 19: E62–E65.
- 8Soltys KA, Mazariegos GV, Strauss KA. Living related transplantation for MSUD–caution, or a new path forward? Pediatr Transplant 2015: 19: 247–248.
- 9Feier F, Benkert AR, Neto JS, et al. Living related versus deceased donor liver transplantation for maple syrup urine disease. Mol Genet Metab 2016: doi: 10.1016/j.ymgme.2016.01.005.
- 10Khanna A, Hart M, Nyhan WL, Hassanein T, Panyard-Davis J, Barshop BA. Domino liver transplantation in maple syrup urine disease. Liver Transpl 2006: 12: 876–882.
- 11Popescu I, Dima SO. Domino liver transplantation: How far can we push the paradigm? Liver Transpl 2012: 18: 22–28.
- 12Shellmer DA, DeVito Dabbs A, Dew MA, et al. Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: A case series. Pediatr Transplant 2011: 15: 58–64.
- 13Matsunami M, Ishiguro A, Fukuda A, et al. Successful living domino liver transplantation in a child with protein C deficiency. Pediatr Transplant 2015: 19: E70–E74.
Citing Literature
